The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues

The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues

Abstract Background Hepatocellular carcinoma (HCC) remains one of the most common cancers worldwide and tends to be detected at an advanced stage. More effective biomarkers for HCC screening and prognosis assessment are needed and the mechanisms of HCC require further exploration. The role of MAOA i...

Full description

Bibliographic Details
Main Authors: Yu‐Yan Pang, Jian‐Di Li, Li Gao, Xia Yang, Yi‐Wu Dang, Ze‐Feng Lai, Li‐Min Liu, Jie Yang, Hua‐Yu Wu, Rong‐Quan He, Zhi‐Guang Huang, Dan‐Dan Xiong, Li‐Hua Yang, Lin Shi, Wei‐Jia Mo, Deng Tang, Hui‐Ping Lu, Gang Chen
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Cancer Medicine
Subjects:
gene chip
HCC
immunohistochemical staining
MAOA
RNA‐seq
tissue microarray
Online Access:https://doi.org/10.1002/cam4.3434

Internet

https://doi.org/10.1002/cam4.3434

Similar Items